Abstract
We genotyped six folate metabolic pathway genes for 11 polymorphisms in 460 cases of childhood acute lymphoblastic leukemia (ALL) and 552 ethnically matched controls. None of the polymorphisms except the 66A>G (I22M) in the 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR) gene showed any effect on disease risk. The carriers of the G-allele were associated with a marginal decreased risk of ALL (gender-adjusted global P=0.03; multiple-testing corrected P=0.25). Analysis of four polymorphisms in the MTRR gene showed statistically significant differences in haplotype distribution between cases and controls (global P<0.0001). The haplotypes GCAC (odds ratio (OR) 0.5, 95% confidence interval (CI) 0.4–0.6) and ATAC (OR 0.5, 95% CI 0.3–0.6) were associated with a reduced risk and the haplotypes ACAC (OR 2.3, 95% CI 1.8–2.9) and GTAC (OR 1.8, 95% CI 1.4–2.3) with an increased risk. The genotype-combination analyses indicated that the best model stratifies cases and controls based on the 66A>G and the 524C>T polymorphisms in the MTRR gene (global P=0.03). Our results suggest that, besides a weak association of childhood ALL with the 66A>G polymorphism, haplotypes within the MTRR gene may, in part, account for population-based differences in risk.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Canalle R, Burim RV, Tone LG, Takahashi CS . Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Environ Mol Mutagen 2004; 43: 100–109.
Greaves MF . Aetiology of acute leukaemia. Lancet 1997; 349: 344–349.
Meier M, den Boer ML, Hall AG, Irving JA, Passier M, Minto L et al. Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia. Leukemia 2005; 19: 1887–1895.
Zeller B, Gustafsson G, Forestier E, Abrahamsson J, Clausen N, Heldrup J et al. Acute leukaemia in children with Down syndrome: a population-based Nordic study. Br J Haematol 2005; 128: 797–804.
McNally RJ, Eden TO . An infectious aetiology for childhood acute leukaemia: a review of the evidence. Br J Haematol 2004; 127: 243–263.
Couto E, Chen B, Hemminki K . Association of childhood acute lymphoblastic leukaemia with cancers in family members. Br J Cancer 2005; 93: 1307–1309.
Greaves MF, Maia AT, Wiemels JL, Ford AM . Leukemia in twins: lessons in natural history. Blood 2003; 102: 2321–2333.
Greaves M . Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 2006; 6: 193–203.
Cheok MH, Evans WE . Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy. Nat Rev Cancer 2006; 6: 117–129.
Pakakasama S, Mukda E, Sasanakul W, Kadegasem P, Udomsubpayakul U, Thithapandha A et al. Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia. Am J Hematol 2005; 79: 202–205.
Rocha JC, Cheng C, Liu W, Kishi S, Das S, Cook EH et al. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood 2005; 105: 4752–4758.
Krajinovic M, Sinnett H, Richer C, Labuda D, Sinnett D . Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int J Cancer 2002; 97: 230–236.
Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 1999; 96: 12810–12815.
Robien K, Ulrich CM . 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a Huge minireview. Am J Epidemiol 2003; 157: 571–582.
Krajinovic M, Lamothe S, Labuda D, Lemieux-Blanchard E, Theoret Y, Moghrabi A et al. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 2004; 103: 252–257.
Skibola CF, Smith MT, Hubbard A, Shane B, Roberts AC, Law GR et al. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 2002; 99: 3786–3791.
Thirumaran RK, Gast A, Flohr T, Burwinkel B, Bartram C, Hemminki K et al. MTHFR genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Blood 2005; 106: 2590–2591, author reply 2591–2592.
Schnakenberg E, Mehles A, Cario G, Rehe K, Seidemann K, Schlegelberger B et al. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population. BMC Med Genet 2005; 6: 23.
Devlin B, Roeder K . Genomic control for association studies. Biometrics 1999; 55: 997–1004.
Thirumaran RK, Bermejo JL, Rudnai P, Gurzau E, Koppova K, Goessler W et al. Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. Carcinogenesis 2006; 27: 1676–1681.
Westfall PH, Young SS . Resampling-Based Multiple Testing. John Wiley & Sons: New York, 1993, pp. 1–360.
Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA . Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425–434.
Sharp L, Little J . Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol 2004; 159: 423–443.
Gemmati D, Ongaro A, Scapoli GL, Della Porta M, Tognazzo S, Serino ML et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev 2004; 13: 787–794.
Gaughan DJ, Kluijtmans LA, Barbaux S, McMaster D, Young IS, Yarnell JW et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 2001; 157: 451–456.
Zavadakova P, Fowler B, Suormala T, Novotna Z, Mueller P, Hennermann JB et al. cblE type of homocystinuria due to methionine synthase reductase deficiency: functional correction by minigene expression. Hum Mutat 2005; 25: 239–247.
Wilson A, Leclerc D, Rosenblatt DS, Gravel RA . Molecular basis for methionine synthase reductase deficiency in patients belonging to the cblE complementation group of disorders in folate/cobalamin metabolism. Hum Mol Genet 1999; 8: 2009–2016.
Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, Ratnasinghe DL, Dawsey SM, Dong ZW et al. Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev 2003; 12: 1222–1226.
Shi Q, Zhang Z, Li G, Pillow PC, Hernandez LM, Spitz MR et al. Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: a case–control analysis. Pharmacogenet Genomics 2005; 15: 547–555.
Zhang Z, Shi Q, Liu Z, Sturgis EM, Spitz MR, Wei Q . Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case–control analysis. Cancer Epidemiol Biomarkers Prev 2005; 14: 1188–1193.
Vaughn JD, Bailey LB, Shelnutt KP, Dunwoody KM, Maneval DR, Davis SR et al. Methionine synthase reductase 66A → G polymorphism is associated with increased plasma homocysteine concentration when combined with the homozygous methylenetetrahydrofolate reductase 677C → T variant. J Nutr 2004; 134: 2985–2990.
de Jonge R, Hooijberg JH, van Zelst BD, Jansen G, van Zantwijk CH, Kaspers GJ et al. Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia. Blood 2005; 106: 717–720.
Crawford DC, Nickerson DA . Definition and clinical importance of haplotypes. Annu Rev Med 2005; 56: 303–320.
Mori H, Colman SM, Xiao Z, Ford AM, Healy LE, Donaldson C et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA 2002; 99: 8242–8247.
Acknowledgements
We gratefully acknowledge BFM Study Group for their support. The study was supported by an EU grant New Generis (FOOD-CT-2005-016320).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)
Supplementary information
Rights and permissions
About this article
Cite this article
Gast, A., Bermejo, J., Flohr, T. et al. Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case–control study. Leukemia 21, 320–325 (2007). https://doi.org/10.1038/sj.leu.2404474
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404474
Keywords
This article is cited by
-
The prevalence and clinical relevance of 2R/2R TYMS genotype in patients with gastrointestinal malignancies treated with fluoropyrimidine-based chemotherapy regimens
The Pharmacogenomics Journal (2021)
-
Folate deficiency as predisposing factor for childhood leukaemia: a review of the literature
Genes & Nutrition (2017)
-
Current evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia
International Journal of Hematology (2013)
-
Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE)
Cancer Causes & Control (2012)
-
Methionine synthase reductase A66G polymorphism contributes to tumor susceptibility: evidence from 35 case–control studies
Molecular Biology Reports (2012)